bibliographicCitation |
Houston A, Bennett MW, O'Sullivan GC, Shanahan F, O'Connell J. Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-β expression. British Journal of Cancer. 2003 Sep 30;89(7):1345–51. doi: 10.1038/sj.bjc.6601240. |